Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease
Direct Payment
$60,000.00
Human Visceral Pain Mechanisms
EF 2011-12
Résumé
Chronic visceral pain (CVP) (e.g. pain arising from the gastrointestinal tract) is one of the most frequent reasons for seeking health care. Pain can arise from organic disease, e.g. inflammatory bowel disease (IBD), but in fact 50% of all patients presenting with visceral pain have no detectable structural or biochemical abnormalities. These patients are categorized as having a functional gastrointestinal disorder such as irritable bowel syndrome (IBS). The mechanisms of CVP are poorly understood. There is increasing evidence that CVP increases sensitivity, or hypersensitivity, of nerve fibres that sense stimuli within the gut. However, drug development has lacked direction due to a rush to extrapolate from the normal condition or from animals to humans. Therefore there is a need to for a translational program that can identify targets within the human gut to treat CVP. This project will involve electrical recordings as well as chemical coding to identify differnt subtypes of sensory nerves within the human gastrointestinal tract. We will then use different drugs to identify potential targets within these sensory nerves. Finally, we will use tissues from resections of IBD patients and patients with acute appendicitis to determine how these targets change during inflammation. Furthermore, we will use tissue resections from hypersensitive appendix patients to determine how previously identified targets are changed in CVP. As a result, this project will identify targets involved in pain that can be modulated during inflammatory and functional bowel disorders.
Programme
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Bénéficiaire
Emplacement
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
243164
Name
Reed David E
Country
United Kingdom
Orgtype
Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario); Crohn's and Colitis Canada (Toronto, Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Human Visceral Pain Mechanisms
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$60,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
Electrophysiology; Human Visceral Pain; Hypersensitivity; Inflammatory Bowel Disease; Irritable Bowel Syndrome; Pharmacology; Visceral Afferents
Abstract
Chronic visceral pain (CVP) (e.g. pain arising from the gastrointestinal tract) is one of the most frequent reasons for seeking health care. Pain can arise from organic disease, e.g. inflammatory bowel disease (IBD), but in fact 50% of all patients presenting with visceral pain have no detectable structural or biochemical abnormalities. These patients are categorized as having a functional gastrointestinal disorder such as irritable bowel syndrome (IBS). The mechanisms of CVP are poorly understood. There is increasing evidence that CVP increases sensitivity, or hypersensitivity, of nerve fibres that sense stimuli within the gut. However, drug development has lacked direction due to a rush to extrapolate from the normal condition or from animals to humans. Therefore there is a need to for a translational program that can identify targets within the human gut to treat CVP. This project will involve electrical recordings as well as chemical coding to identify differnt subtypes of sensory nerves within the human gastrointestinal tract. We will then use different drugs to identify potential targets within these sensory nerves. Finally, we will use tissues from resections of IBD patients and patients with acute appendicitis to determine how these targets change during inflammation. Furthermore, we will use tissue resections from hypersensitive appendix patients to determine how previously identified targets are changed in CVP. As a result, this project will identify targets involved in pain that can be modulated during inflammatory and functional bowel disorders.
Competitiondate
201110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Reed, David E
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $60,000~ $0~